C-ABL-IN-5
C-ABL-IN-5 is a selective c-Abl inhibitor with neuroprotective effects. c-ABL-IN-5 has blood-brain barrier penetrability, metabolic stability and good pharmacokinetic properties. When c-ABL-IN-5 is labeled with [18F] (compound [18F]3), it can be used as a tracer to evaluate disease-modifying efficacy by complementary positron emission tomography (PET) . c-ABL-IN-5 can be used in the study of neurodegenerative diseases such as Parkinson's disease (PD) [1].
Product Specifications
UNSPSC
12352005
Target
Bcr-Abl
Type
Reference compound
Related Pathways
Protein Tyrosine Kinase/RTK
Applications
Neuroscience-Neurodegeneration
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/c-abl-in-5.html
Solubility
10 mM in DMSO
Smiles
O=C(NC1=CN2C=C(C=CC2=N1)C3=CC=CC=C3CCF)[C@H]4[C@H](C4)F
Molecular Formula
C19H17F2N3O
Molecular Weight
341.35
References & Citations
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
SARS-CoV-2 (AY.3) Spike S1+S2 trimer Protein (His)
SARS-CoV-2 (AY.3) Spike S1+S2 trimer Protein (His)
SARS-CoV-2 (AY.3) Spike S1+S2 trimer Protein (His)
SARS-CoV-2 (AY.3) Spike S1+S2 trimer Protein (His)